Cytek Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CTKB, updated each market day.
CTKB AI Sentiment
AI sees no strong directional signal for Cytek Biosciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Cytek Biosciences, Inc. Common Stock
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Sector
Exchange
Market Cap
$593,901,628
Cap Tier
Employees
702
Headquarters
FREMONT, CA
Listed Since
July 23, 2021
Website
CTKB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CTKB Volatility
Cytek Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
